CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of Timed Sequential Busulfan in Combination With Fludarabine in Allogeneic Stem Cell Transplantation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01572662
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:05.819933+00:00
Published At: 2023-06-29T00:00:00+00:00
Record Updated At: 2023-06-29
Results Posted At: 2023-06-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Leukemia", "Acute Myeloid Leukemia", "Acute Lymphocytic Leukemia", "Chronic Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Myeloproliferative Diseases", "Non-Hodgkins Lymphoma", "Hodgkins Lymphoma", "Multiple Myeloma", "Myelodysplastic Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-06-29"
protocolSection.identificationModule.nctId: "NCT01572662"
protocolSection.identificationModule.officialTitle: "Phase II Study of Timed Sequential Busulfan in Combination With Fludarabine in Allogeneic Stem Cell Transplantation"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-06-29"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.